#1 Clinical Trials Search in Europe

Temocillin

This article summarizes several clinical trials investigating the use of temocillin, an antibiotic medication, for treating various bacterial infections. Temocillin is being studied as a potential alternative to other antibiotics, particularly for infections caused by antibiotic-resistant bacteria. The trials examine temocillin’s effectiveness, safety, and optimal dosing in different patient populations and types of infections.

Table of Contents

What is Temocillin?

Temocillin, also known by its brand name Negaban, is an antibiotic medication that belongs to the penicillin family[1]. It was originally developed in the 1980s but was largely abandoned until recent years when it has gained renewed interest due to its effectiveness against certain types of antibiotic-resistant bacteria[1][2].

Temocillin is unique because it has a special chemical structure that makes it resistant to many types of enzymes (called beta-lactamases) that bacteria produce to defend themselves against antibiotics. This means that temocillin can still work against some bacteria that have become resistant to other antibiotics[1].

Uses of Temocillin

Temocillin is primarily used to treat infections caused by a group of bacteria called Gram-negative bacteria. It is particularly useful for treating infections caused by bacteria that have developed resistance to other antibiotics. The main uses of temocillin include:

  • Urinary Tract Infections (UTIs): Temocillin is effective against complicated UTIs, including those caused by bacteria that produce extended-spectrum beta-lactamases (ESBLs)[2][3].
  • Respiratory Tract Infections: It can be used to treat lower respiratory tract infections[1].
  • Bloodstream Infections: Temocillin is used to treat bacteremia, which is the presence of bacteria in the blood[4].
  • Abdominal Infections: It can be effective against certain types of abdominal infections[1].

How Temocillin Works

Temocillin works by interfering with the way bacteria build their cell walls. Without properly functioning cell walls, bacteria cannot survive. What makes temocillin special is its ability to resist breakdown by certain bacterial enzymes (beta-lactamases) that typically destroy other antibiotics in the penicillin family[1].

The effectiveness of temocillin is related to how long it stays at a high enough concentration in the body. For optimal effect, the concentration of temocillin in the blood needs to be above a certain level (called the minimum inhibitory concentration or MIC) for at least 40% to 70% of the time between doses[1].

Administration and Dosage

Temocillin is typically given as an intravenous (IV) infusion, which means it’s administered directly into a vein. The usual adult dose is 2 grams given every 12 hours or every 8 hours, depending on the severity of the infection[1][2].

For children, the dose is usually calculated based on their weight. The typical dose is 25-50 mg per kilogram of body weight per day, divided into two or three doses[5].

The duration of treatment can vary depending on the type and severity of the infection, but it typically ranges from 7 to 14 days[2].

Effectiveness

Temocillin has shown good effectiveness against many types of Gram-negative bacteria, including those that have developed resistance to other antibiotics. It’s particularly useful against bacteria that produce enzymes called extended-spectrum beta-lactamases (ESBLs), which can make many other antibiotics ineffective[2][6].

Studies have shown that temocillin can be as effective as other powerful antibiotics (like carbapenems) for treating certain types of infections, while potentially having less impact on the body’s normal bacterial flora[3][6].

Side Effects

Like all medications, temocillin can cause side effects, although not everyone experiences them. Some potential side effects include:

  • Diarrhea
  • Pain at the injection site
  • Rash
  • Fever
  • Joint or muscle pain

In rare cases, more serious side effects like severe allergic reactions (anaphylaxis) can occur. If you experience any severe side effects or signs of an allergic reaction (such as difficulty breathing, severe rash, or swelling), seek medical attention immediately[1].

Special Considerations

Temocillin is primarily eliminated from the body through the kidneys. This means that for patients with kidney problems, the dose may need to be adjusted. In patients undergoing hemodialysis (a treatment for kidney failure), special dosing schedules may be used[7].

Temocillin should not be used in patients who have a known allergy to penicillin antibiotics[1].

Ongoing Research

Researchers are continually studying temocillin to better understand its uses and effectiveness. Current areas of research include:

  • Comparing temocillin to other antibiotics for treating various types of infections[6][3].
  • Studying the appropriate dosing of temocillin in different patient groups, including children and patients with kidney problems[5][7].
  • Investigating whether temocillin could be a good alternative to other powerful antibiotics, potentially helping to combat antibiotic resistance[8].

These ongoing studies aim to provide more information about how best to use temocillin to treat infections effectively while minimizing the risk of antibiotic resistance.

Trial Focus Key Findings/Objectives Patient Population
Pharmacokinetics in non-ICU patients Characterize temocillin pharmacokinetics and optimize dosing Adults with complicated UTIs, respiratory, or abdominal infections
Efficacy in ESBL UTIs Evaluate efficacy of high-dose temocillin (6g/day) for resistant UTIs Adults with UTIs caused by ESBL-producing bacteria
Pharmacokinetics in children Determine appropriate dosing for pediatric patients Children with UTIs, cholangitis, or post-transplant prophylaxis
Comparison to carbapenems for bacteremia Assess non-inferiority of temocillin vs. meropenem Adults with bacteremia due to resistant Enterobacteriaceae
Impact on intestinal microbiota Compare ecological effects of temocillin vs. cefotaxime Adults with febrile UTIs

FAQ

  • What is temocillin? Temocillin is an antibiotic medication that belongs to the penicillin class. It is active against many Gram-negative bacteria, including those that produce certain antibiotic-resistant enzymes called beta-lactamases.
  • What types of infections is temocillin being studied for? Temocillin is being investigated for treating urinary tract infections, bloodstream infections, and other severe infections caused by antibiotic-resistant Gram-negative bacteria, particularly in hospital and intensive care settings.
  • How is temocillin given to patients? Temocillin is typically administered intravenously (through an IV). The dosage and frequency can vary depending on the type of infection and the patient's kidney function, ranging from 2 grams every 8-12 hours to 6 grams per day as a continuous infusion.
  • What are the potential advantages of temocillin over other antibiotics? Temocillin may be effective against certain antibiotic-resistant bacteria while potentially causing less disruption to the normal gut bacteria compared to broader-spectrum antibiotics. It is being studied as an alternative to carbapenems in some cases to help reduce the development of further antibiotic resistance.
  • Are there any special considerations for using temocillin in patients with kidney problems? Yes, temocillin dosing needs to be adjusted in patients with reduced kidney function. Some studies are specifically looking at how to optimally dose temocillin in patients on dialysis.

Ongoing Clinical Trials on Temocillin

  • Study on the Effectiveness of Co-Trimoxazole for Treating Ventilator-Associated Pneumonia in ICU Patients Compared to a Drug Combination

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France

Glossary

  • Extended-spectrum beta-lactamases (ESBLs): Enzymes produced by some bacteria that can break down and cause resistance to many common antibiotics, making infections harder to treat.
  • Carbapenem: A class of powerful broad-spectrum antibiotics often reserved for treating serious infections caused by multidrug-resistant bacteria.
  • Pharmacokinetics: The study of how a drug moves through the body, including how it is absorbed, distributed, metabolized, and eliminated.
  • Pharmacodynamics: The study of how a drug affects the body, including its mechanism of action and the relationship between drug concentration and effect.
  • Minimum Inhibitory Concentration (MIC): The lowest concentration of an antibiotic that prevents visible growth of a bacterium.
  • Enterobacteriaceae: A large family of Gram-negative bacteria that includes many common pathogens such as E. coli and Klebsiella.
  • Gram-negative bacteria: A class of bacteria that do not retain crystal violet dye in a laboratory staining procedure. Many antibiotic-resistant pathogens belong to this group.
  • Bacteremia: The presence of bacteria in the bloodstream, which can lead to serious infections throughout the body.
  • Pyelonephritis: A type of urinary tract infection that affects one or both kidneys.
  • Empiric treatment: Antibiotic treatment started before the specific cause of an infection is known, based on clinical symptoms and likely pathogens.

References

  1. https://clinicaltrials.gov/study/NCT03557840
  2. https://clinicaltrials.gov/study/NCT02681263
  3. https://clinicaltrials.gov/study/NCT02959957
  4. https://clinicaltrials.eu/trial/56672/
  5. https://clinicaltrials.gov/study/NCT02260102
  6. https://clinicaltrials.gov/study/NCT03543436
  7. https://clinicaltrials.gov/study/NCT02285075
  8. https://clinicaltrials.gov/study/NCT05565222